Oxidized LOw-density lipoprotein sensitizes human vascular smooth muscle cells to FAS (CD95)-mediated apoptosis

被引:9
作者
Takarada, S [1 ]
Imanishi, T [1 ]
Hano, T [1 ]
Nishio, I [1 ]
机构
[1] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama 6418510, Japan
关键词
apoptosis; Fas; Fas ligand; oxidized low-density lipoprotein; vascular smooth muscle cells;
D O I
10.1046/j.1440-1681.2003.03829.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. It was investigated in the present study whether oxidized low-density lipoprotein (oxLDL) was implicated in the susceptibility of human vascular smooth muscle cells (VSMC) to Fas-mediated death. Human fetal aorta smooth muscle cells were treated with agonistic anti-Fas antibody (CH11) and oxLDL and cell death was then determined by viability and DNA fragmentation. 2. The results of the present study show that cross-linking of Fas receptor with anti-Fas antibody in the presence of oxLDL induced death and DNA fragmentation in human VSMC, which were blocked by the caspase inhibitor z-VAD.fmk, followed by the upregulation of cell surface Fas. 3. The data indicate that oxLDL is implicated in death in VSMC and provide evidence that oxLDL is involved in Fas signal transduction. The present study proposes a novel mechanism(s) by which VSMC become susceptible to Fas ligand. 4. One of the mechanisms proposed by which oxLDL upregulates cell surface Fas is by inhibiting the degradation of Fas through the ubiquitin-proteasome pathway.
引用
收藏
页码:289 / 294
页数:6
相关论文
共 33 条
[1]   Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis [J].
Bennett, M ;
Macdonald, K ;
Chan, SW ;
Luzio, JP ;
Simari, R ;
Weissberg, P .
SCIENCE, 1998, 282 (5387) :290-293
[2]   APOPTOSIS OF HUMAN VASCULAR SMOOTH-MUSCLE CELLS DERIVED FROM NORMAL VESSELS AND CORONARY ATHEROSCLEROTIC PLAQUES [J].
BENNETT, MR ;
EVAN, GI ;
SCHWARTZ, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2266-2274
[3]   ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS [J].
BERLINER, JA ;
NAVAB, M ;
FOGELMAN, AM ;
FRANK, JS ;
DEMER, LL ;
EDWARDS, PA ;
WATSON, AD ;
LUSIS, AJ .
CIRCULATION, 1995, 91 (09) :2488-2496
[4]  
Bjorkerud S, 1996, AM J PATHOL, V149, P367
[5]   The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions [J].
Cai, WJ ;
Devaux, B ;
Schaper, W ;
Schaper, J .
ATHEROSCLEROSIS, 1997, 131 (02) :177-186
[6]  
Dimmeler S, 1997, CIRCULATION, V95, P1760
[7]  
Dong CM, 1996, LAB INVEST, V74, P921
[8]  
ENARI M, 1995, EMBO J, V14, P5201, DOI 10.1002/j.1460-2075.1995.tb00204.x
[9]   Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover [J].
French, LE ;
Hahne, M ;
Viard, I ;
Radlgruber, G ;
Zanone, R ;
Becker, K ;
Muller, C ;
Tschopp, J .
JOURNAL OF CELL BIOLOGY, 1996, 133 (02) :335-343
[10]   Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta [J].
Geng, YJ ;
Wu, Q ;
Muszynski, M ;
Hansson, GK ;
Libby, P .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (01) :19-27